DFCM
BEAM icon

Dark Forest Capital Management’s Beam Therapeutics BEAM Stock Holding History

Dark Forest Capital Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-307
Closed -$9.4K – 1053
2023
Q1 		$9.4K Buy
+307
New +$12.1K ﹤0.01% 1036
2022
Q1 		– Sell
-1,286
Closed -$102K – 1292
2021
Q4 		$102K Buy
+1,286
New +$110K 0.04% 338

Other funds holding BEAM

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dark Forest Capital Management's BEAM Position: Q2 2023 in Review

Dark Forest Capital Management sold out of Beam Therapeutics (BEAM) in Q2 2023, closing a stake of 307 shares — an estimated $9.4K sold.

Dark Forest Capital Management first reported a position in BEAM in Q4 2021 and held it in 2 quarters. The position peaked at $102K in Q4 2021. 193 funds tracked by Wall St. Rank hold BEAM as of Q2 2023.

  • Dark Forest Capital Management reported no remaining Beam Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Dark Forest Capital Management sold 307 Beam Therapeutics shares in Q2 2023, an estimated $9.4K.
  • Dark Forest Capital Management first reported a position in Beam Therapeutics in Q4 2021 and held it in 2 quarters.
  • Dark Forest Capital Management's Beam Therapeutics position peaked at $102K in Q4 2021.
  • 193 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2023.

Based on Dark Forest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.